Imsidolimab
Imsidolimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Imsidolimab is under investigation in clinical trial NCT03633396 (A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis).
| Trade Name | Imsidolimab |
| Generic | Imsidolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Imsidolimab
